Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.85 EUR | +1.19% | +2.40% | +2.87% |
12:02am | US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59 | RE |
06-07 | Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds | RE |
MarketScreener Strategies
Filters
- Stock Market
- Equities
- PFE Stock
- PFE Stock
- News Pfizer, Inc.
- MarketScreener Strategies